Today at Biotech Focus Conference 2021: Client Replimune to Participate

Replimune, a client of Westwood & Wilshire, will have its President and Chief Research & Development Officer, Robert Coffin, join a panel at the William Blair Biotech Focus Conference 2021. The panel will be titled “Novel Mechanisms and Strategies for Addressing PD-(L)1 Refractory/Resistant Tumors,” and will stream virtually today, Wednesday July 14, at 4:20 pm EST. The recording will be available to stream for 90 days, under the investors section of Replimune’s website.

Westwood & Wilshire currently leads Replimune’s search efforts for Vice President and Head of Medical Affairs. The company uses its Immunlytic platform to develop oncolystic immune-gene therapies to fight cancer. Replimune’s platform is designed to maximize systemic immune activation and is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment across a broad range of cancers. We are very excited to see a client participate in the Biotech Focus Conference, along with dozens of other top biotechs.

We here at Westwood & Wilshire are excited to tune into the Dr. Coffin’s panel, and hope you’ll join us here.